Top Sites>PharmaBoardroom - PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.

Sitemap: https://pharmaboardroom.com/wp-sitemap.xml

# START YOAST BLOCK
# ---------------------------
User-agent: *
Disallow:

# ---------------------------
# END YOAST BLOCK

# PharmaBoardroom: PharmaBoardroom provides industry trends, news and reports from all over the world\. This site is for senior professionals who want to understand local and global markets\.

> PharmaBoardroom is a global platform that connects the experiences and expertise of C\-level executives throughout the world\. Covering management strategy, regulatory reforms, R\&D, market access and pricing, PharmaBoardroom offers a seat at the table with pharma leaders and decision makers\. We do this by providing unparalleled content that informs, engages and inspires senior professionals to help them understand global trends and strategies and translate them into local realities\.

Generated by Yoast SEO v27.1.1, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Media Kit](https://pharmaboardroom.com/mediakit/)
- [Home](https://pharmaboardroom.com/)
- [Library](https://pharmaboardroom.com/library/)
- [BioTech](https://pharmaboardroom.com/biotech/)
- [Editor Page](https://pharmaboardroom.com/editor/)

## Memberships
- [Member](https://pharmaboardroom.com/register/member/)

## Files
- [InFocus: Lyon](https://pharmaboardroom.com/mp-files/infocus-lyon.pdf/)
- [In Vivo CAR\-T: China’s Clinical Data Lead](https://pharmaboardroom.com/mp-files/in-vivo-car-t-chinas-clinical-data-lead.pdf/)
- [Healthcare \& Life Sciences Review France 2026](https://pharmaboardroom.com/mp-files/healthcare-life-sciences-review-france-2026.pdf/)
- [Healthcare \& Life Sciences Review Latin America 2026](https://pharmaboardroom.com/mp-files/healthcare-life-sciences-review-latin-america-2026.pdf/)
- [Switzerland Pharma Report 2025](https://pharmaboardroom.com/mp-files/switzerland-pharma-report-2025.pdf/)

## Articles
- [China Biotech M\&A, Licensing \& Clinical Development Roundup](https://pharmaboardroom.com/articles/china-biotech-ma-licensing-clinical-development-roundup/)
- [Taiwan’s CDMOs to Know: Replicating Semiconductor Success, Capturing the China Pivot, Cell \& Gene Therapy Specialisation](https://pharmaboardroom.com/articles/taiwans-cdmos-to-know-replicating-semiconductor-success-capturing-the-china-pivot-cell-gene-therapy-specialisation/)
- [The European Health Data Space \(EHDS\): A Breakthrough Moment in Sharing Health Data \- Are We Ready for Implementation?](https://pharmaboardroom.com/articles/the-european-health-data-space-ehds-a-breakthrough-moment-in-sharing-health-data-are-we-ready-for-implementation/)
- [The WuXi Alumni: How China's Top CDMO Fosters the Next Generation of Biotech Leaders](https://pharmaboardroom.com/articles/the-wuxi-alumni-how-chinas-top-cdmo-fosters-the-next-generation-of-biotech-leaders/)
- [European Life Sciences: Time for Change on Valuing Innovation](https://pharmaboardroom.com/articles/european-life-sciences-time-for-change-on-valuing-innovation/)

## Interviews
- [Joe Yeh \- Founder \& CEO, aetherAI](https://pharmaboardroom.com/interviews/joe-yeh-founder-ceo-aetherai/)
- [Long Sheng Fan \- CEO, Iridium Medical Technology](https://pharmaboardroom.com/interviews/long-sheng-fan-ceo-iridium-medical-technology/)
- [Terry Wong \- CEO, Hong Kong Science and Technology Parks Corporation \(HKSTP\)](https://pharmaboardroom.com/interviews/terry-wong-ceo-hong-kong-science-and-technology-parks-corporation-hkstp/)
- [Tina Graves \- General Manager, GSK Taiwan](https://pharmaboardroom.com/interviews/tina-graves-general-manager-gsk-taiwan/)
- [Vera Zheng \- SVP Asia/Pacific Strategy \& Head of Greater China, Parexel International](https://pharmaboardroom.com/interviews/vera-zheng-svp-asia-pacific-strategy-head-of-greater-china-parexel-international/)

## Sponsored
- [Why Lack of Consensus on ‘Digital Twins’ Is Hindering Progress Across Pharma](https://pharmaboardroom.com/sponsored/why-lack-of-consensus-on-digital-twins-is-hindering-progress-across-pharma/)
- [Service as Strategy: How Olympus Is Raising Medtech Standards Across META](https://pharmaboardroom.com/sponsored/service-as-strategy-how-olympus-is-raising-medtech-standards-across-meta/)
- [Expanding Oncology Access in Some of Europe’s Most Complex Markets](https://pharmaboardroom.com/sponsored/expanding-oncology-access-in-some-of-europes-most-complex-markets/)
- [Guangjin Pan – Managing Director, Centre for Regenerative Medicine and Health, Hong Kong Institute of Science \& Innovation, Chinese Academy of Science](https://pharmaboardroom.com/sponsored/professor-guangjin-pan-managing-director-centre-for-regenerative-medicine-and-health-hong-kong-institute-of-science-innovation-chinese-academy-of-science/)
- [Dana Vigier – VP, Central and Northern Europe Area Head, Alexion, AstraZeneca Rare Disease](https://pharmaboardroom.com/sponsored/dana-vigier-vp-central-and-northern-europe-area-head-alexion-astrazeneca-rare-disease/)

## Legal Handbooks
- [The Pharma Legal Handbook: Slovakia](https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-slovakia/)
- [The Pharma Legal Handbook:  Asia Growth \& Transition Market](https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-asia-growth-transition-market/)
- [Market Access \& Health Technology Assesment: Romania](https://pharmaboardroom.com/legal-reports/market-access-health-technology-assesment-romania/)
- [The Pharma Legal Handbook: Panama](https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-panama/)
- [The Pharma Legal Handbook: Baltics](https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-baltics/)

## Country Reports
- [Switzerland Pharma Report 2025](https://pharmaboardroom.com/country-reports/switzerland-pharma-report-2025/)
- [Healthcare \& Life Sciences Review France 2026](https://pharmaboardroom.com/country-reports/healthcare-life-sciences-review-france-2026/)
- [Healthcare \& Life Sciences Review Latin America 2026](https://pharmaboardroom.com/country-reports/healthcare-life-sciences-review-latin-america-2026/)
- [Denmark Country Report 2025](https://pharmaboardroom.com/country-reports/denmark-country-report-2025/)
- [Saudi Arabia Pharma Report 2025](https://pharmaboardroom.com/country-reports/saudi-arabia-pharma-report-2025/)

## Pharma Report
- [Denmark Pharma Report 2021](https://pharmaboardroom.com/pharma-reports/denmark-pharma-report-2021/)
- [Turkey Pharma Report 2021](https://pharmaboardroom.com/pharma-reports/turkey-pharma-report-2021/)
- [InFigures Asia\-Pacific 2021](https://pharmaboardroom.com/pharma-reports/infigures-asia-pacific-2021/)
- [InFigures Asia\-Pacific 2020](https://pharmaboardroom.com/pharma-reports/infigures-asia-pacific-2020/)
- [Middle East \& North Africa Pharma Data By Country Report 2020](https://pharmaboardroom.com/pharma-reports/middle-east-north-africa-pharma-data-by-country-report-2020/)

## E\-books
- [InFocus: Lyon](https://pharmaboardroom.com/e-books/infocus-lyon/)
- [In Vivo CAR\-T: China's Clinical Data Lead](https://pharmaboardroom.com/e-books/in-vivo-car-t-chinas-clinical-data-lead/)
- [InFocus: China Biotech Catalysts Q4 2025](https://pharmaboardroom.com/e-books/infocus-china-biotech-catalysts-q4-2025/)
- [InFocus: Cell \& Gene Therapy in Hong Kong](https://pharmaboardroom.com/e-books/infocus-cell-gene-therapy-in-hong-kong/)
- [InFocus: The Future of HIV](https://pharmaboardroom.com/e-books/infocus-the-future-of-hiv/)

## Legal Articles
- [Marketing, Manufacturing, Packaging \& Labeling, Advertising: Romania](https://pharmaboardroom.com/legal-articles/marketing-manufacturing-packaging-labeling-advertising-romania/)
- [Traditional Medicines and OTC Products: Panama](https://pharmaboardroom.com/legal-articles/traditional-medicines-and-otc-products-panama/)
- [Biosimilars \& Biologics: Panama](https://pharmaboardroom.com/legal-articles/biosimilars-biologics-panama/)
- [Orphan Drugs \& Rare Diseases: Panama](https://pharmaboardroom.com/legal-articles/orphan-drugs-rare-diseases-panama/)
- [Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Panama](https://pharmaboardroom.com/legal-articles/cannabinoid-drugs-medicinal-cannabis-and-opioid-drugs-panama/)

## Legal Partners
- [Osterling Abogados](https://pharmaboardroom.com/partners/osterling-abogados/)
- [Youssry Saleh Law Firm](https://pharmaboardroom.com/partners/youssry-saleh-law-firm/)
- [Marval, O'Farrell \& Mairal](https://pharmaboardroom.com/partners/marval-ofarrell-mairal/)
- [Mușat \& Asociații](https://pharmaboardroom.com/partners/mușat-asociații/)
- [Simonsen Vogt Wiig](https://pharmaboardroom.com/partners/simonsen-vogt-wiig/)

## Companies
- [Roche China](https://pharmaboardroom.com/directory/roche-china/)
- [MCS Puerto Rico](https://pharmaboardroom.com/directory/mcs-puerto-rico/)
- [Pharma\-Bio Serv – Puerto Rico](https://pharmaboardroom.com/directory/pharma-bio-serv-puerto-rico/)
- [Creative Peptides](https://pharmaboardroom.com/directory/creative-peptides/)
- [IBSA Farmaceutici](https://pharmaboardroom.com/directory/ibsa-italy/)

## Facts
- [Hong Kong Biotech IPOs in 2025](https://pharmaboardroom.com/facts/hong-kong-biotech-ipos-in-2025/)
- [MEA Pharma Market Growth 2020\-2024](https://pharmaboardroom.com/facts/mea-pharma-market-growth-2020-2024/)
- [European Medicines Agency ATMP Approvals 2009\-2025](https://pharmaboardroom.com/facts/european-medicines-agency-atmp-approvals-2009-2025/)
- [Top 20 Chinese Pharma Companies](https://pharmaboardroom.com/facts/top-20-chinese-pharma-companies/)
- [Regulatory Momentum: Swissmedic Approvals Up 12% in 2024](https://pharmaboardroom.com/facts/regulatory-momentum-swissmedic-approvals-up-12-in-2024/)

## Partners News
- [Lumanity Acquires Innovative Edge](https://pharmaboardroom.com/partners-news/lumanity-acquires-innovative-edge/)
- [Forecasting the Transformation and Future Directions of Global Healthcare in the Post\-Covid Era](https://pharmaboardroom.com/partners-news/forecasting-the-transformation-and-future-directions-of-global-healthcare-in-the-post-covid-era/)
- [Introduction of 2021 China BioMed Innovation and Investment Conference](https://pharmaboardroom.com/partners-news/introduction-of-2021-china-biomed-innovation-and-investment-conference/)
- [Dan\*na launches a pilot plant for bioplastic production for the biomedical and technological sector in the Barcelona Science Park](https://pharmaboardroom.com/partners-news/danna-launches-a-pilot-plant-for-bioplastic-production-for-the-biomedical-and-technological-sector-in-the-barcelona-science-park/)
- [ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drug Development in China and Singapore, Advised by MSQ Ventures](https://pharmaboardroom.com/partners-news/adc-therapeutics-and-overland-pharma-form-strategic-jv-to-expand-adc-drug-development-in-china-and-singapore-advised-by-msq-ventures/)

## Contributors
- [Miriam Galdova](https://pharmaboardroom.com/contributors/miriam-galdova/)
- [Ján Lančarič](https://pharmaboardroom.com/contributors/jan-lancaric/)
- [Unjela Kaleem](https://pharmaboardroom.com/contributors/unjela-kaleem/)
- [Joonho Choi](https://pharmaboardroom.com/contributors/joonho-choi/)
- [John Murphy III](https://pharmaboardroom.com/contributors/john-murphy-iii/)

## InFocus
- [InFocus Vaccines](https://pharmaboardroom.com/infocus/infocus-vaccines/): Long dismissed as the backwaters of healthcare innovation, the tremendous value of vaccines – the single most cost\-effective health intervention after clean water – made itself starkly clear in 2020, as the discovery of a novel coronavirus quickly exploded into a full\-blown global pandemic that rages on still\.

While billions have since been poured into vaccine development for COVID\-19 and vaccine candidates have been developed and approved \(albeit so far only for emergency use\) at unprecedented speed, sector stakeholders are only cautiously optimistic regarding the longevity of this newly awakened global interest and investment in vaccines – and whether the frenetic zeal to discovering and deploying COVID\-19 vaccines would translate into sustained and longer\-term efforts to support vaccine R\&D for a whole host of other infectious diseases that continue to claim tens of millions of lives annually\.

This issue of InFocus dedicated to vaccines features a variety of global, regional and local stakeholders across the public and private spheres to provide a snapshot of the four thematics at the heart of the vaccine sector: Research \& Development, Manufacturing \& Supply Chain, Partnership Models, and Public Health Impact\.
- [InFocus Patient Engagement in the Era of CAR\-T](https://pharmaboardroom.com/infocus/patient-engagement-in-the-era-of-cart/)
- [InFocus Rare Diseases](https://pharmaboardroom.com/infocus/rare-diseases/): Long regarded as a neglected backwater within the drug discovery landscape and the preserve of only a handful of niche players, the rare disease space has been undergoing an extraordinary turnaround in fortunes of
- [Marc Boutin \- Global Head of Patient Engagement](https://pharmaboardroom.com/infocus/marc-boutin-global-head-of-patient-engagement/): “How are you today?” For patients, this question may be a challenge\. Honest answers can stop a conversation straight away\. I know what I am talking about\. 25 years ago, a series of tragic diagnoses hit my family\. Over a short period, all diagnosed loved ones passed from cancer, HIV and other diseases\. A decade later I became a patient myself, suffering from cancer and an autoimmune disease\. I could feel the pain of giving a polite answer to the conversational “how are you today?” question myself\.
- [InFocus Homepage](https://pharmaboardroom.com/infocus/home-page/): PharmaBoardroom’s InFocus channel covers key topics from across the industry\. InFocus offers exposure to key decision making industry individuals across both PharmaExecutives and wider ecosystem through value and unique content\.
InFocus positions your company as thought leaders and drivers for change through its association of quality relevant content driving knowledge and debate across the industry\. Lead Generation through ebooks and Sponsored articles offer opportunities to widen your reach and target your content and messaging to our valuable audience and beyond\. Our content library hosts white papers by the industry's leading solution providers\.

## HubsGoGlobal
- [Company Stories](https://pharmaboardroom.com/hubsgoglobal/company-stories/): New companies move to and invest in Western Switzerland every year, becoming part of its extraordinarily diverse business community or strengthening their presence in the country\. Among them is a steady flow of life sciences companies\.
- [Establishing a Company](https://pharmaboardroom.com/hubsgoglobal/establishing-a-company/): Creating a company in Switzerland is an easy and rapid operation involving only moderate costs\. As the official investment promotion agency for Western Switzerland, GGBa will be pleased to answer all your questions related to available legal structures, taxes, the choice of a specific site and employee recruiting, thereby allowing you to manage your project according to your schedule\.
- [Flawless Operations](https://pharmaboardroom.com/hubsgoglobal/flawless-operations/): Switzerland stands out as an operation base thanks to three major factors\. The first is infrastructure and logistics; a dense network of road, rail, and air connections combined with efficient utilities, postal services, and healthcare, ensures that the country is extremely well connected, both internally and externally\. Secondly, Switzerland’s 31 free trade agreements \(FTAs\) with 41 partners ensure barrier\-free trade with global partners\. Thirdly, highly competitive corporate taxation rates mean that companies, especially those focused on innovation and R\&D, can thrive\. 

- [GGBA \- HOME](https://pharmaboardroom.com/hubsgoglobal/ggba-home/): It’s a favorable environment for developing our business activities, because many biomedical companies, research centers and startups are located in the region

Thibaud Stoll, Head of Merck’s Global Biotech Manufacturing
- [Message From Our Director](https://pharmaboardroom.com/hubsgoglobal/message-from-our-director-2/): Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite the COVID\-19 pandemic, highlights some of the key recent investments in the Greater Geneva Bern area \(GGBa\), and gives an overview of what the region has to offer global companies across the life sciences value chain\.

## Categories
- [NEWS \> TRENDING](https://pharmaboardroom.com/category/latest-pharma-news/)
- [NEWS \> PRESS RELEASES](https://pharmaboardroom.com/category/pharmaceutical-business-news/)
- [hubsgoglobal](https://pharmaboardroom.com/category/hubsgoglobal-post/)
- [ggba](https://pharmaboardroom.com/category/hubsgoglobal-post/ggba-hubsgoglobal-post/)
- [Company Stories](https://pharmaboardroom.com/category/hubsgoglobal-post/company-stories/)

## Tags
- [CEO](https://pharmaboardroom.com/tag/ceo/)
- [news](https://pharmaboardroom.com/tag/news/)
- [partners](https://pharmaboardroom.com/tag/partners/)
- [test1](https://pharmaboardroom.com/tag/test1/)
- [partner news](https://pharmaboardroom.com/tag/partner-news/)

## Countries
- [China](https://pharmaboardroom.com/countries/china/)
- [France](https://pharmaboardroom.com/countries/france/)
- [Mexico](https://pharmaboardroom.com/countries/mexico/)
- [Switzerland](https://pharmaboardroom.com/countries/switzerland/)
- [USA](https://pharmaboardroom.com/countries/usa/)

## File Tags
- [Global](https://pharmaboardroom.com/file-tag/global/)
- [Biosimilars](https://pharmaboardroom.com/file-tag/biosimilars/)
- [Spain](https://pharmaboardroom.com/file-tag/spain/)
- [Pharma](https://pharmaboardroom.com/file-tag/pharma/)
- [Report](https://pharmaboardroom.com/file-tag/report/)

## File Categories
- [Country Reports](https://pharmaboardroom.com/file-category/country-reports/)
- [eBooks](https://pharmaboardroom.com/file-category/ebooks/)
- [White Papers](https://pharmaboardroom.com/file-category/white-papers/)

## Optional
- [Sitemap index](https://pharmaboardroom.com/wp-sitemap.xml)